AccurKardia
United States
- New York, NY
- 22/06/2023
- Seed
- $2,700,000
AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. AccurKardia combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device, and at the edge. The Company is part of Cohort 3 of Mayo Clinic Platform_Accelerate and first 510(k) filing is under review by FDA.
- Industry Software Development
- Website https://www.accurkardia.com/
- LinkedIn https://www.linkedin.com/company/accurkardia/
Related People
Juan C JimenezCo Founder
United States -
ND
Founded in 2019, AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. AccurKardia combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device, and at the edge.
Lucky Energy | $25,000,000 | (Nov 13, 2025)
Vend Park | $17,500,000 | (Nov 13, 2025)
BoomPop | $41,000,000 | (Nov 13, 2025)
Quality Means Business | $2,000,000 | (Nov 13, 2025)
REBEL | $25,000,000 | (Nov 13, 2025)
Modulight Biotherapeutics | $12,000,000 | (Nov 13, 2025)
Frugal | $5,000,000 | (Nov 13, 2025)
Humanix | $18,000,000 | (Nov 13, 2025)
Ladder Bio Inc. | $5,500,000 | (Nov 13, 2025)
GC AI | $60,000,000 | (Nov 13, 2025)
BITE Data | $2,500,000 | (Nov 11, 2025)
EVE(1) | $2,000,000 | (Nov 11, 2025)